Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 501

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Suppression of tumor growth through disruption of hypoxia-inducible transcription

Kung, Andrew L., Wang, Stream, Klco, Jeffery M., Kaelin, William G., Livingston, David M.·2000·Nature Medicine

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/82146

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 38

  1. Wang, G.L., Jiang, B.H., Rue, E.A. & Semenza, G.L. Hypoxia-inducible factor 1 is a basic-HLH-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92, 5510–5514 (1995). · DOI · Paper page
  2. Salceda, S. & Caro, J. HIF-1α protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272, 22642–22647 (1997). · DOI · Paper page
  3. Huang, L.E., Arany, Z., Livingston, D.M. & Bunn, H.F. Activation of HIF depends primarily upon redox-sensitive stabilization of its α subunit. J. Biol. Chem. 271, 32253–32259 (1996). · DOI · Paper page
  4. Cockman, M.E. et al. HIF-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275, 25733–25741 (2000). · DOI · Paper page
  5. Ohh, M. et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nature Cell Biol. 2, 423–427 (2000). · DOI · Paper page
  6. Arany, Z. et al. An essential role for p300/CBP in the cellular response to hypoxia. Proc. Natl. Acad. Sci. USA 93, 12969–12973 (1996). · DOI · Paper page
  7. Ebert, B.L. & Bunn, H.F. Regulation of transcription by hypoxia requires a multiprotein complex that includes HIF-1, an adjacent transcription factor and p300/CREB binding protein. Mol. Cell. Biol. 18, 4089–4096 (1998). · DOI · Paper page
  8. Kallio, P.J. et al. Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 co-activator by the HIF-1α. EMBO J. 17, 6573–6586 (1998). · DOI · Paper page
  9. Carrero, P. et al. Redox-regulated recruitment of the transcriptional co-activators CREB-binding protein and SRC-1 to HIF-1α. Mol. Cell. Biol. 20, 402–415 (2000). · DOI · Paper page
  10. Semenza, G.L. & Wang, G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12, 5447–5454 (1992). · DOI · Paper page
  11. Nordsmark, M., Bentzen, S.M. & Overgaard, J. Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity. Acta Oncol. 33, 383–389 (1994). · DOI · Paper page
  12. Helmlinger, G., Yuan, F., Dellian, M. & Jain, R.K. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nature Med. 3, 177–182 (1997). · DOI · Paper page
  13. Brown, J.M. Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol. Med. Today. 6, 157–162 (2000). · DOI · Paper page
  14. Zhong, H. et al. Overexpression of HIF-1α in common human cancers and their metastases. Cancer Res. 59, 5830–5835 (1999).
  15. Hockel, M. et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56, 4509–4515 (1996).
  16. Brizel, D.M. et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56, 941–943 (1996).
  17. Zeman, E. M., Brown, J. M., Lemmon, M. J., Hirst, V. K. & Lee, W. W. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. Int. J. Radiat. Oncol. Biol. Phys. 12, 1239–1242 (1986). · DOI · Paper page
  18. Binley, K., Iqball, S., Kingsman, A., Kingsman, S. & Naylor, S. An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer. Gene Ther. 6, 1721–1727 (1999). · DOI
  19. Shibata, T., Giaccia, A.J. & Brown, J.M. Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Ther. 7, 493–498 (2000). · DOI · Paper page
  20. Jiang, B.H., Zheng, J.Z., Leung, S.W., Roe, R. & Semenza, G.L. Transactivation and inhibitory domains of HIF-1α. Modulation of transcriptional activity by oxygen tension. J. Biol. Chem. 272, 19253–19260 (1997). · DOI · Paper page
  21. Wilson, I. A. et al. Identical short peptide sequences in unrelated proteins can have different conformations: a testing ground for theories of immune recognition. Proc. Natl. Acad. Sci. USA 82, 5255–5259 (1985). · DOI
  22. Chakravarti, D. et al. Role of CBP/P300 in nuclear receptor signalling. Nature 383, 99–103 (1996). · DOI · Paper page
  23. Oliner, J.D., Andresen, J.M., Hansen, S.K., Zhou, S. & Tjian, R. SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein. Genes Dev. 10, 2903–2911 (1996). · DOI
  24. Yao, T.P., Ku, G., Zhou, N., Scully, R. & Livingston, D.M. The nuclear hormone receptor co-activator SRC-1 is a specific target of p300. Proc. Natl. Acad. Sci. USA 93, 10626–10631 (1996). · DOI · Paper page
  25. Bhattacharya, S. et al. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α. Nature 383, 344–347 (1996). · DOI · Paper page
  26. Carmeliet, P. et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485–490 (1998). · DOI · Paper page
  27. Ryan, H.E., Lo, J. & Johnson, R.S. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J 17, 3005–3015 (1998). · DOI · Paper page
  28. Maxwell, P.H. et al. HIF-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 94, 8104–8109 (1997). · DOI · Paper page
  29. Ryan, H.E. et al. HIF-1α is a positive factor in solid tumor growth. Cancer Res. 60, 4010–015 (2000).
  30. Zhong, H. et al. Modulation of HIF-1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60, 1541–1545 (2000).
  31. Jiang, B.H., Rue, E., Wang, G.L., Roe, R. & Semenza, G.L. Dimerization, DNA binding and transactivation properties of HIF-1. J. Biol. Chem. 271, 17771–17778 (1996). · DOI · Paper page
  32. Kamei, Y. et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403–414 (1996). · DOI · Paper page
  33. Horvai, A.E. et al. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc. Natl. Acad. Sci. USA 94, 1074–1079 (1997). · DOI · Paper page
  34. Foster, B.A., Coffey, H.A., Morin, M.J. & Rastinejad, F. Pharmacological rescue of mutant p53 conformation and function. Science 286, 2507–2510 (1999). · DOI · Paper page
  35. Fukumura, D. et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 94, 715–725 (1998). · DOI · Paper page
  36. Ausubel, F.M. et al. (eds.) Current Protocols in Molecular Biology (Wiley-Interscience, New York, 1988).
  37. LaVallie, E.R. et al. A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Biotechnology (NY) 11, 187–193 (1993).
  38. Bhattacharya, S. et al. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev. 13, 64–75 (1999). · DOI · Paper page

Cited by

See all 501

Metadata

Authors
Kung, A. L., Wang, S., Klco, J. M., Kaelin, W. G., & Livingston, D. M.
Venue
Nature Medicine
Published
2000-12
Volume
6
Issue
12
Pages
1335-1340
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W1543662618
Cited by
501
References
7
FWCI
15.92
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Suppression of tumor growth through disruption of hypoxia-inducible transcription. https://app.cochat.ai/papers/10.1038/82146
The paper
Kung, A. L., Wang, S., Klco, J. M., Kaelin, W. G., & Livingston, D. M. (2000). Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nature Medicine. https://doi.org/10.1038/82146

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.